Published 19:47 IST, July 6th 2020
Mylan Pharma to launch Remdesivir in India at Rs 4,800 for COVID-19 treatment
Pharmaceutical company Mylan NV has said that it has secured the approval of Drug Controller General of India (DCGI) for the manufacture of its Remdesivir.
null | Image:
self
- Listen to this article
- 2 min read
Advertisement
19:47 IST, July 6th 2020